Skip to main content
. 2018 Mar 1;2018:8512745. doi: 10.1155/2018/8512745

Figure 4.

Figure 4

Western blot analysis showed an increased expression of Beclin-1 and LC3-II and a decreased expression of p62 in the NP cells treated with PPARγ agonist. # represents a significant difference from 0.2 M high glucose condition (p < .05).